Neuron23
Developer of an artificial intelligence-based drug discovery model designed for genetically defined neurological and immunological diseases. The company's platform leverages recent advances in human g...
Valuation
$271.5M
Latest known
Share Price
N/A
Total Raised
$310M
Last Round
N/A